SCHEMBL16202425

SCHEMBL16202425

O=C1C(O)[C@H](O)C(O)[C@@H](O)[C@H]1O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
APP P05067 1/20 0.39
GBA1 P04062 1/20 0.35
IDUA P35475 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4363795 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL13114117 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL14590784 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL12858510 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL12858507 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL12858980 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL13114129 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL1681832 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL12411897 1.00 LMNA (0.39) LMNAAPPGBA1IDUA
SCHEMBL16204481 1.00 LMNA (0.39) LMNAAPPGBA1IDUA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140322775-A1 METHOD FOR PRODUCING SCYLLO-INOSITOL HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140322775-A1 METHOD FOR PRODUCING SCYLLO-INOSITOL ME1, IMPDH2, ITPA LMNA 3636/4885APP 3819/4885GBA1 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.